Novavax Aktie 

157,68EUR
±0,00EUR
±0,00%
23.06.2021
191,00USD
-3,37USD
-1,73%
01:57:30
Hier für 0 Euro handeln mit
mehr Daten anzeigen
Werbung

Profil Novavax

Die Novavax Inc. Aktie wird unter der ISIN US6700024010 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Hamburg, Berlin, Hannover, NASDAQ, Mexiko, Bats, BX World, NDB, Gettex, Tradegate, Lang & Schwarz, Baader Bank und Quotrix gehandelt. Novavax Inc. ist ein Unternehmen aus den USA. Unternehmen aus der Peer Group von Novavax Inc. sind Bayer, BioNTech (ADRs), CureVac, Fresenius Medical Care AG & Co. KGaA (FMC) St., Fresenius SE & Co. KGaA (St.), Gilead Sciences Inc., Inovio Pharmaceuticals Inc, Novartis AG, Pfizer Inc. und Roche AG (Genussschein).

Novavax Aktionärsstruktur

Inhaberin %
Freefloat99,15
The Vanguard Group, Inc.8,79
Vanguard Group, Inc. (Subfiler)7,79
Fidelity Management & Research Co. LLC6,35
D. E. Shaw & Co. LP4,93
RA Capital Management LP4,06
BlackRock Fund Advisors3,90
BlackRock Institutional Trust Co. NA2,63
Vanguard Total Stock Market Index Fund2,43
Vanguard Small Cap Index Fund2,11
Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Novavax Personal

20162017201820192020
Personal am Ende des Jahres355347379165791
Umsatz pro Mitarbeiter in Mio. USD0,040,090,090,110,60

Novavax Bilanz (in Mio. USD) - Aktiva

20162017201820192020
Summe Umlaufvermögen288203119971.248
Summe Anlagevermögen3112161511461.109
Summe Aktiva3943022081731.582

Novavax Bilanz (in Mio. USD) - Passiva

20162017201820192020
Gesamtverschuldung/ -verbindlichkeiten316318319332482
Summe Fremdkapital400404376359955
Summe Eigenkapital-6-102-168-186627
Summe Passiva3943022081731.582

Adresse

21 Firstfield Road, 20878 Gaithersburg
Tel:1.240.268.2000
Fax:
Internethttp://www.novavax.com
Werbung

Management

Biegie Lee
Chief Information Officer & Senior Vice President
Brian Rosen
Senior Vice President-Commercial Strategy
Chris Dunne
Vice President-Finance
David M. Mott
Independent Director
Erika Trahan
Senior Manager-Investor & Public Relations
Filip Dubovsky
Chief Medical Officer & Executive Vice President
Frank D. Czworka
Senior Vice President-Global Sales
Gale E. Smith
Chief Scientist & Senior Vice President-Discovery
Gregg H. Alton
Independent Director
Gregory M. Glenn
President-Research & Development
Henrietta Ukwu
Chief Regulatory & Quality Officer, Senior VP
Iksung Cho
Vice President-Biostatistics
James F. Young
Chairman
Jill Hoyt
Chief Human Resources Officer & Executive VP
John A. Herrmann
Secretary, Chief Legal Officer & Executive VP
John J. Trizzino
CFO, EVP, Chief Commercial & Business Officer
Margaret G. McGlynn
Independent Director
Michael A. McManus
Independent Director
Rachel K. King
Independent Director
Rajiv Indravadan Modi
Director
Richard Crowley
Chief Operating Officer & Executive Vice President
Richard H. Douglas
Independent Director
Russell P. Wilson
Senior Vice President-Business Development
Silvia Taylor
Senior VP-Investor Relations & Corporate Affairs
Stanley C. Erck
President, Chief Executive Officer & Director
Sven Arne Andréasson
Senior Vice President-Corporate Development
Timothy Jon Hahn
Senior Vice President-Process Technology
Troy Morgan
Chief Compliance Officer & Senior Vice President
finanzen.net Brokerage
finanzen.net Zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln